Walleye Capital
IDNA icon

Walleye Capital’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Walleye Capital’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,538
Closed -$292K – 4552
2023
Q1 		$292K Buy
+12,538
New +$314K ﹤0.01% 2149

Other funds holding IDNA

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Walleye Capital's IDNA Position: Q2 2023 in Review

Walleye Capital sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q2 2023, closing a stake of 12,538 shares — an estimated $292K sold.

Walleye Capital first reported a position in IDNA in Q1 2023 and held it in 1 quarter. The position peaked at $292K in Q1 2023. 67 funds tracked by Wall St. Rank hold IDNA as of Q2 2023.

  • Walleye Capital reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q2 2023 after selling out during the quarter.
  • Walleye Capital sold 12,538 iShares Genomics Immunology and Healthcare ETF shares in Q2 2023, an estimated $292K.
  • Walleye Capital first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2023 and held it in 1 quarter.
  • Walleye Capital's iShares Genomics Immunology and Healthcare ETF position peaked at $292K in Q1 2023.
  • 67 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2023.

Based on Walleye Capital's 13F filing for Q2 2023, filed 14 Aug 2023.